Neuren Pharmaceuticals | NEU - Ativo Circulante





Ativo Circulante Alterar Data
Akebia Therapeutics USD 243.48M 9.47M 2026-03
Alaunos Therapeutics USD 970K 1.02M 2026-03
Avita Medical AUD 35.49M 760K 2025-12
Clinuvel Pharmaceuticals AUD 261.38M 1.59M 2025-12
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Genetic Signatures AUD 42.96M 5.02M 2025-12
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Medical Developments International AUD 33.75M 1.79M 2025-12
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organon & Co USD 4.93B 580M 2026-03
Paradigm Biopharmaceuticals AUD 21.67M 2.46M 2025-12
PYC Therapeutics AUD 153.74M 23.79M 2025-12
Starpharma Holdings AUD 24.24M 1.68M 2025-12
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Telix Pharmaceuticals AUD 330.28M 67.73M 2025-12
Viatris USD 10.92B 1.13B 2026-03
Xeris Pharmaceuticals USD 251.68M 11.37M 2026-03